Aromatase inhibitors are used in the treatment of hormone receptor-positive, early, and metastatic breast cancer in postmenopausal women and, sometimes, in men with gynecomastia. They stop the production of estrogen in postmenopausal women by blocking the enzyme aromatase. The aromatase enzyme turns the hormone androgen into small amounts of estrogen in the body.